HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gabriel Steg Selected Research

Thrombosis (Thrombus)

10/2016Frequency of Stent Thrombosis Risk at 5 Years in Women Versus Men With Zotarolimus-Eluting Compared With Sirolimus-Eluting Stent.
4/2016Correlates of pre-hospital morphine use in ST-elevation myocardial infarction patients and its association with in-hospital outcomes and long-term mortality: the FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) programme.
3/2013Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors.
9/2012Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes-insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
3/2011Rationale and design of the INFUSE-AMI study: A 2 × 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gabriel Steg Research Topics

Disease

13Hemorrhage
02/2021 - 01/2010
10Myocardial Infarction
01/2022 - 12/2002
10Acute Coronary Syndrome
02/2021 - 04/2005
8Stroke (Strokes)
01/2022 - 09/2012
6ST Elevation Myocardial Infarction
06/2022 - 10/2009
5Coronary Artery Disease (Coronary Atherosclerosis)
11/2021 - 04/2005
5Thrombosis (Thrombus)
10/2016 - 03/2011
4Heart Failure
08/2015 - 06/2003
2Diabetes Mellitus
10/2016 - 08/2015
1COVID-19
04/2022
1Pneumonia (Pneumonitis)
04/2022
1Type 2 Diabetes Mellitus (MODY)
01/2022
1Chronic Obstructive Pulmonary Disease (COPD)
12/2021
1MINOCA
11/2021
1Chronic Renal Insufficiency
02/2021
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
12/2020
1Overweight
01/2020
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2020
1Thrombocytopenia (Thrombopenia)
12/2017
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2016
1Chest Pain (Chest Pains)
04/2016
1Pain (Aches)
04/2016
1Non-ST Elevated Myocardial Infarction
04/2016
1Coronary Disease (Coronary Heart Disease)
02/2013
1Infarction (Infarctions)
03/2011
1Intermittent Claudication
11/2010
1Hematoma
01/2010
1Hypertension (High Blood Pressure)
05/2009
1Cardiovascular Diseases (Cardiovascular Disease)
01/2009
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
01/2009
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2009
1Hypersensitivity (Allergy)
06/2008
1Necrosis
04/2005
1Dyspnea (Shortness of Breath)
06/2003
1Atrioventricular Block
12/2002
1Ischemia
12/2002
1Ventricular Tachycardia
12/2002

Drug/Important Bio-Agent (IBA)

5Clopidogrel (Plavix)FDA Link
11/2021 - 11/2011
5TicagrelorIBA
02/2021 - 09/2012
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2019 - 06/2008
32'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
11/2021 - 01/2019
3omega-Chloroacetophenone (Mace)IBA
01/2019 - 06/2013
3Abciximab (ReoPro)FDA Link
02/2012 - 12/2002
3Brain Natriuretic Peptide (Natrecor)FDA Link
01/2006 - 06/2003
2Hemoglobins (Hemoglobin)IBA
12/2021 - 01/2010
2Prasugrel HydrochlorideFDA Link
02/2021 - 02/2013
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
04/2016 - 02/2013
2AnticoagulantsIBA
06/2013 - 10/2009
2bivalirudin (Angiomax)FDA Link
08/2012 - 03/2011
2Glycoproteins (Glycoprotein)IBA
07/2011 - 03/2011
2Enoxaparin (Lovenox)FDA LinkGeneric
07/2011 - 01/2010
2AntithrombinsIBA
07/2011 - 06/2008
1Oxygen (Dioxygen)IBA
04/2022
1Dexamethasone (Maxidex)FDA LinkGeneric
04/2022
1tocilizumab (atlizumab)FDA Link
04/2022
1(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA
01/2022
1Glucagon-Like Peptide ReceptorsIBA
01/2022
1Sodium-Glucose Transport ProteinsIBA
01/2022
1Glucagon-Like Peptide 1 (GLP 1)IBA
01/2022
1LDL CholesterolIBA
12/2020
1LipidsIBA
12/2020
1RubidiumIBA
01/2020
1Sirolimus (Rapamycin)FDA Link
10/2016
1zotarolimusIBA
10/2016
1Morphine (MS Contin)FDA LinkGeneric
04/2016
1Opioid Analgesics (Opioids)IBA
04/2016
1Cytochrome P-450 CYP2C19IBA
04/2016
1saxagliptinFDA Link
08/2015
1Indicators and Reagents (Reagents)IBA
03/2015
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
03/2013
1Purinergic P2Y Receptor AntagonistsIBA
02/2013
1Fondaparinux (Arixtra)FDA Link
08/2012
1Heparin (Liquaemin)FDA LinkGeneric
07/2011
1Retinaldehyde (Retinal)IBA
05/2009
1Pharmaceutical PreparationsIBA
01/2009
1Biomarkers (Surrogate Marker)IBA
04/2005

Therapy/Procedure

12Therapeutics
11/2021 - 12/2002
9Percutaneous Coronary Intervention
06/2022 - 01/2010
4Stents
10/2016 - 03/2011
3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
11/2011 - 12/2002
2Thrombolytic Therapy
06/2008 - 12/2002
1Artificial Respiration (Mechanical Ventilation)
04/2022
1Blood Transfusion (Blood Transfusions)
01/2018
1Length of Stay
08/2012
1Thrombectomy
03/2011
1Surgical Amputation (Amputations)
11/2010
1Punctures
01/2010